2019
DOI: 10.3390/ijms20030642
|View full text |Cite
|
Sign up to set email alerts
|

Cyclodextrin–Drug Inclusion Complexes: In Vivo and In Vitro Approaches

Abstract: This review aims to provide a critical review of the biological performance of natural and synthetic substances complexed with cyclodextrins, highlighting: (i) inclusion complexes with cyclodextrins and their biological studies in vitro and in vivo; (ii) Evaluation and comparison of the bioactive efficacy of complexed and non-complexed substances; (iii) Chemical and biological performance tests of inclusion complexes, aimed at the development of new pharmaceutical products. Based on the evidence presented in t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

4
168
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 275 publications
(187 citation statements)
references
References 90 publications
4
168
0
2
Order By: Relevance
“…The problem of the low solubility of many drugs has been overcome by complexation of the active principle ingredient with a-, b-, or c-cyclodextrins, and 2-hydroxypropyl-b-cyclodextrin (HP-b-CD) as well. HP-b-CD, is the most widely used modified cyclodextrin, has excellent inclusion properties for many compounds, is less toxic, safe, and an effective drug carrier (Gould & Scott, 2005;Misiuk & Zalewska, 2009;Folch Cano et al, 2014;Srivalli & Mishra, 2016;Carneiro et al, 2019). Previously, HP-b-CD was used to form the inclusion complex with enrofloxacin to increase its aqueous solubility and stability.…”
Section: Introductionmentioning
confidence: 99%
“…The problem of the low solubility of many drugs has been overcome by complexation of the active principle ingredient with a-, b-, or c-cyclodextrins, and 2-hydroxypropyl-b-cyclodextrin (HP-b-CD) as well. HP-b-CD, is the most widely used modified cyclodextrin, has excellent inclusion properties for many compounds, is less toxic, safe, and an effective drug carrier (Gould & Scott, 2005;Misiuk & Zalewska, 2009;Folch Cano et al, 2014;Srivalli & Mishra, 2016;Carneiro et al, 2019). Previously, HP-b-CD was used to form the inclusion complex with enrofloxacin to increase its aqueous solubility and stability.…”
Section: Introductionmentioning
confidence: 99%
“…CDs are cyclic oligosaccharides used for the improvement of water-solubility and bioavailability of medicinal products. Their key feature is the hydrophobic internal cavity, that provides the ability to form complexes with a variety of guest molecules resulting with the formation of encapsulation complexes [18]. The encapsulation can influence the stability of nutraceutical in gastrointestinal tract by reducing the rate of hydrolysis, oxidation, stearic rearrangement, racemization, enzymatic decomposition, or formation of complexes with other food components which, all together, can have significant impact on nutraceutical bioaccessibility.…”
mentioning
confidence: 99%
“…CD have been used as a pharmaceutical excipient able to increase the solubility of drugs. These cyclic oligosaccharides also exhibit stable physicochemical characteristics capable of protecting host molecules from degradation in the gastrointestinal tract and against oxidation, provide photo and thermal stability, and reduce physiological effects, undesirable organoleptic characteristics, drug volatility and toxicity [20][21][22][23][24][25].…”
Section: Introductionmentioning
confidence: 99%